Hamide Nasiri | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Hamide Nasiri | Neuroscience | Best Researcher Award

Dr. Hamide Nasiri, Zanjan University of Medical Sciences, Iran

Hamideh Nasiri is a highly motivated medical student at Zanjan University of Medical Sciences, Iran, with a strong research focus in neurobiology, cognitive neuroscience, and neuroimaging. Her work primarily explores the intersection of computational neuroscience with clinical neurology, addressing topics like brain connectivity, neurodegenerative diseases, and ischemic stroke. With multiple publications in top-tier journals such as Discover Medicine, Molecular Brain, and Neurological Sciences, Nasiri has established herself as a prominent emerging researcher in neuroscience. Her commitment to advancing our understanding of brain diseases is also evident through her participation in international conferences and her role as a peer reviewer for several respected journals. Apart from her academic pursuits, she actively contributes to her community and is an honored student at Zanjan University.

Professional Profile

Scopus

orcid

Research for Best Researcher Award: Hamide Nasiri

Hamide Nasiri’s academic and research background showcases her as an exceptional candidate for the Research for Best Researcher Award. As a medical student at Zanjan University of Medical Sciences in Iran, Hamide has delved deep into various subfields of neuroscience, including neurobiology, cognitive neuroscience, neuroimaging, and computational neuroscience. Her extensive list of publications, particularly in high-impact journals like Discover Medicine, Molecular Brain, and Archives of Gerontology and Geriatrics, highlights her dedication to advancing knowledge in the understanding of neurological conditions such as stroke, Alzheimer’s disease, and mild cognitive impairment.

One of her standout contributions is her work on neurofilament light chains and brain morphometry, with a focus on dementia spectrum disorders. Her research on biomarkers and brain connectivity, particularly using advanced imaging techniques like fMRI and EEG, is instrumental in advancing diagnostic and therapeutic approaches for neurodegenerative diseases. This makes her work highly relevant to both clinical neuroscience and computational modeling fields.

Education 

Hamideh Nasiri is currently a medical student at Zanjan University of Medical Sciences in Iran, where she has been honing her skills in various aspects of health, including pharmacology, human physiology, and neurological disorders. Her academic journey began in September 2020 and is expected to conclude in 2027. Throughout her education, Nasiri has focused on building a strong foundation in both clinical and theoretical aspects of medicine, with particular emphasis on neuroscience and cognitive health. She has demonstrated excellence in her coursework and research, achieving a Top 0.1% ranking in Iran's National University Entrance Exam (Tajtobi Konkur) in 2020. Additionally, she earned a diploma in the Biology Olympiad in 2017, further highlighting her academic dedication. Nasiri's impressive academic trajectory showcases her commitment to becoming a leader in the field of neurobiology and cognitive neuroscience.

Professional Experience

Hamideh Nasiri has garnered substantial experience in both research and teaching. As a medical student at Zanjan University of Medical Sciences, she is actively involved in research focused on neurobiology, cognitive neuroscience, and neuroimaging. She has authored numerous high-impact research articles, some of which have been published in leading journals such as Discover Medicine, Molecular Brain, and Neurological Sciences. Nasiri also serves as a peer reviewer for prestigious journals, contributing to the scientific community's advancement. In addition to her research endeavors, she has accumulated valuable teaching experience. From April 2023 to September 2024, she tutored courses on writing essays, articles, and data analysis, helping her peers develop essential academic and research skills. Through these experiences, Nasiri has built a solid reputation as both a researcher and educator, demonstrating leadership and team collaboration skills while contributing significantly to her field.

Awards and Recognition 

Hamideh Nasiri has earned numerous accolades that recognize her outstanding academic and research achievements. Among her notable honors, she has been named an Honored Student at Zanjan University of Medical Sciences, where she continues to excel. Her academic prowess was also acknowledged in high school, where she was awarded Honored Student status (2017–2020). Additionally, she achieved an impressive Top 0.1% ranking in Iran's highly competitive National University Entrance Exam (Tajtobi Konkur) in 2020. In 2017, Nasiri earned a diploma in the Biology Olympiad, an accomplishment that highlights her early passion for the sciences. These awards, alongside her significant contributions to the field of neuroscience, have solidified her reputation as a rising star in medical research. Her achievements reflect both her dedication to academic excellence and her commitment to advancing neuroscience research through innovative and impactful work.

Research Skill On Neuroscience

Hamideh Nasiri possesses an extensive range of research skills, particularly in neuroimaging, cognitive neuroscience, and computational neuroscience. Her proficiency in data analysis using tools such as SPSS, Python, and machine learning algorithms is a testament to her technical expertise. Nasiri is skilled in analyzing neuroimaging data with advanced software like SPM12, Explore DTI, and VBM, and she has experience with EEG data analysis through EEGLAB. She has contributed to numerous studies on brain connectivity, neurodegenerative diseases, and cognitive decline, with a particular focus on Alzheimer's disease and ischemic stroke. Furthermore, her ability to conduct advanced statistical analyses, preprocess complex data, and build brain cell models using the Hodgkin-Huxley model demonstrates her deep understanding of neuroscience at both a theoretical and practical level. Nasiri's research skills, paired with her leadership in research teams, position her as an influential figure in the neuroscience field.

Publication Top Notes

  • Title: Elevated serum leucine levels contribute to cognitive impairment through reduction of gray matter and cerebral volume in Alzheimer’s disease
    Authors: Hamide Nasiri, Ali Azargoonjahromi, Zahra Nouri, Sayed Mehrdad Azimi, Hossein Zand, Amir Shourideh, Soudabeh Heydari, Behnaz Mahmoudvand, Somayeh Barabadi, Nastaran Samadpour et al.
    Citation: Nasiri H, Azargoonjahromi A, Nouri Z, et al. Elevated serum leucine levels contribute to cognitive impairment through reduction of gray matter and cerebral volume in Alzheimer’s disease. Neuroscience. 2025; May.

  • Title: Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer’s Disease
    Authors: Ali Azargoonjahromi, Mortaza Eivazi, Hamide Nasiri, Vahideh Tarhriz, Zahra Payandeh
    Citation: Azargoonjahromi A, Eivazi M, Nasiri H, et al. Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer’s Disease. Journal of Molecular Neuroscience. 2025; Mar 20.

  • Title: Thrombolysis Treatment in Patients Who Are Awake and Have an Unknown Duration of Stroke Receiving Effective and Safe Treatment or Who Are Futile and At Risk: A Study-Based SITS
    Authors: Abdoreza Ghoreishi, Hamideh Nasiri, Fatemeh Karami Zarandi, Kaveh Hadiloo
    Citation: Ghoreishi A, Nasiri H, Karami Zarandi F, et al. Thrombolysis Treatment in Patients Who Are Awake and Have an Unknown Duration of Stroke Receiving Effective and Safe Treatment or Who Are Futile and At Risk: A Study-Based SITS. Journal of Advances in Medical and Biomedical Research. 2025; Mar 13.

Mohammed Reyazuddin | Psychiatry | Excellence in Research

Posted on by sciencefather

Dr. Mohammed Reyazuddin | Psychiatry | Excellence in Research

Dr. Mohammed Reyazuddin, JNMCH, AMU, ALIGARH, India

Dr. Mohammed Reyazuddin is a distinguished psychiatrist and academician dedicated to advancing mental health care. Born on September 14, 1982, in India, he earned his MBBS (2006) and MD in Psychiatry (2012) from Jawaharlal Nehru Medical College, Aligarh Muslim University (AMU). With extensive experience in clinical psychiatry, research, and teaching, he has significantly contributed to neuropsychiatric disorders, psychopharmacology, and addiction psychiatry. As an Associate Professor at J.N. Medical College, AMU, he mentors students and conducts pioneering research in treatment-resistant depression, schizophrenia, and obsessive-compulsive disorder (OCD). His work has led to multiple publications, clinical trials, and national projects, including collaborations with the Ministry of Social Justice and Empowerment. Dr. Reyazuddin is fluent in English, Hindi, Urdu, Arabic, and Bengali, allowing him to engage with a diverse patient population. His commitment to mental health awareness and innovative therapies positions him as a leading figure in contemporary psychiatry.

Professional Profile

Scopus

Summary of Suitability for the “Research for Excellence in Research Award”

Dr. Mohammed Reyazuddin stands out as an exceptional candidate for the “Research for Excellence in Research Award,” demonstrating extensive academic and professional expertise in the field of psychiatry. His academic qualifications include an MD in Psychiatry from Jawaharlal Nehru Medical College, Aligarh Muslim University, along with a substantial experience in both teaching and clinical practice. As an Associate Professor at the prestigious J.N. Medical College, Dr. Reyazuddin has contributed significantly to psychiatric education, research, and patient care.

His research work is highly commendable, with a focus on areas such as oxidative stress in schizophrenia, treatment-resistant depression, pharmacogenomics in psychiatry, and the effectiveness of newer therapeutic approaches like rTMS and oral ketamine. Dr. Reyazuddin has supervised numerous postgraduate theses, showcasing his mentorship and commitment to fostering academic growth in the next generation of psychiatrists. Additionally, his role as a co-supervisor in various groundbreaking studies speaks to his leadership and collaboration in advancing psychiatric research.

🎓 Education 

Dr. Mohammed Reyazuddin pursued his MBBS (2006) and MD in Psychiatry (2012) from Jawaharlal Nehru Medical College, AMU, Aligarh. His MBBS journey laid a strong foundation in medical sciences, with a 59% aggregate, followed by an MD where he specialized in clinical psychiatry, neuropsychiatric disorders, and psychopharmacology. His early academic excellence began with 70% in Intermediate (2001) from Senior Secondary School, AMU and 64% in High School (1998) from Modern School, Rishikesh (ICSE Board). Throughout his education, he demonstrated a keen interest in mental health, neuroscience, and pharmacogenomics, leading to groundbreaking research in oxidative stress and antioxidant enzyme levels in schizophrenia. His dedication to academia is evident in his involvement in clinical studies, psychiatric trials, and mentorship of postgraduate theses. His education and continuous learning have solidified his expertise in modern psychiatric interventions and patient-centric mental health care.

💼 Professional Experience

Dr. Mohammed Reyazuddin has over 12 years of experience in psychiatry, serving in clinical, academic, and research capacities. Currently, he is an Associate Professor of Psychiatry at J.N. Medical College, AMU (since August 2024). Previously, he was an Assistant Professor at the same institution (2018-2024) and held similar roles at F.H. Medical College, Tundla, and Rohilkhand Medical College, Bareilly. He contributed to public mental health as a Consultant Psychiatrist in the National Mental Health Program at Aligarh District Hospital (2017-2018). His early career included Senior Residency at J.N. Medical College, AMU (3 years) and an internship across multiple departments. His expertise spans psychopharmacology, forensic psychiatry, neurocognitive disorders, and psychiatric comorbidities in chronic illnesses. With hands-on experience in clinical trials, psychotherapy, and rehabilitation psychiatry, he continues to influence the next generation of psychiatrists and advance evidence-based psychiatric care.

🏅 Awards and Recognition

Dr. Mohammed Reyazuddin has been recognized for his outstanding contributions to psychiatry and mental health research. His achievements include:
🏆 Best Research Paper Award – Indian Journal of Psychiatry for his study on oxidative stress in schizophrenia.
🏆 Excellence in Psychiatry Award – AMU Medical Faculty for his clinical innovations in psychopharmacology.
🏆 Young Psychiatrist Award – Indian Association of Psychiatry for his contributions to addiction treatment and mental health advocacy.
🏆 Distinguished Mentor Award – AMU for guiding postgraduate research in treatment-resistant depression and pharmacogenomics.
🏆 Research Grant Recipient – Indian Council of Medical Research (ICMR) for his work on advance directives in psychotic spectrum disorders.
🏆 Ministry of Social Justice Project Lead – Nodal Officer for Addiction Treatment Facility at JNMCH.
His pioneering research and commitment to patient care have earned him recognition at national and international psychiatry conferences.

🌍 Research Skills On Psychiatry

Dr. Mohammed Reyazuddin specializes in clinical psychiatry, psychopharmacology, neurocognitive disorders, and psychiatric comorbidities. His expertise includes:
🧠 Neuropsychiatric Disorders – Extensive research on schizophrenia, bipolar disorder, and depression.
💊 Psychopharmacology – Investigated novel drug therapies, ketamine use in depression, and rTMS for OCD.
📊 Clinical Trials – Led and co-supervised studies on genetic polymorphisms in schizophrenia and comparative antidepressant efficacy.
🔬 Forensic Psychiatry – Researched mental health policies and psychiatric ethics.
🖥️ Digital Psychiatry – Studied problematic screen use and internet addiction among adolescents.
His research contributions shape evidence-based psychiatric interventions, improving treatment outcomes and mental health policies in India.

📖 Publication Top Notes

Title: Koro-Like Symptoms in an Adolescent Female With Schizophrenia
  • Authors:Abid A. Rizvi, Faisal F. Shaan, Mohammed M. Reyazuddin, F.N.U. Malsawmtluangi, Shreya S. Agrawal
  • Journal: Journal of the American Academy of Child and Adolescent Psychiatry
  • Year: 2024

Scheherazade Le | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Scheherazade Le | Neuroscience | Best Researcher Award

👤 Dr. Scheherazade Le, Stanford, United States

Dr. Scheherazade Le, M.D., is a Clinical Professor in the Department of Neurology at Stanford University. With expertise in epilepsy and electroencephalography (EEG), she specializes in intraoperative neuromonitoring (IONM) and neurophysiology. Dr. Le earned her M.D. from the University of California, San Francisco (UCSF), and completed residency and fellowship training at Stanford University, where she also held the role of Chief Resident. With extensive clinical and academic appointments, Dr. Le is dedicated to advancing medical education in neurology. Her contributions extend to the creation of high-quality teaching curricula and the mentorship of students, residents, and fellows. Her clinical expertise and passion for education have earned her multiple honors, including the A.B. Baker Teacher Recognition Award. Through her innovative teaching and research, Dr. Le has made significant contributions to the field of neuroscience.

Professional Profile

Scopus

🌟 Research for Best Researcher Award Evaluation for Dr. Scheherazade Le, M.D.

Dr. Scheherazade Le, a Clinical Professor in the Department of Neurology at Stanford University, is an exemplary candidate for the Research for Best Researcher Award. Her extensive background in epilepsy, electroencephalography (EEG), and intraoperative neuro-monitoring (IONM) sets her apart as a leader in the field. She holds dual board certifications in adult neurology and epilepsy, which reflect her comprehensive expertise.

Dr. Le’s education and training at prestigious institutions like UCSF and Stanford, coupled with her multiple academic appointments and contributions to the curriculum, have been highly influential. Her role as the co-course director of Stanford’s Neuroscience Block and her efforts in developing innovative neurology curriculum, especially for epilepsy, reflect her deep commitment to advancing education in the medical field. She has consistently received recognition for her excellence in teaching, receiving numerous awards such as the A.B. Baker Teacher Recognition Award from the American Academy of Neurology in 2024.

🎓 Education 

Dr. Scheherazade Le completed her M.D. at the University of California, San Francisco (UCSF) in May 2006, where she focused on medical humanities. Her undergraduate studies were at the University of California, Berkeley (UCB), where she graduated with High Honors in Political Science and received the highest honors for her thesis. Dr. Le pursued residency in Neurology at Stanford University, where she also served as Chief Resident. Afterward, she completed fellowship training in Clinical Neurophysiology at Stanford, specializing in Intraoperative Neuro-Monitoring (IONM) and Epilepsy & Electroencephalography (EEG). Dr. Le’s academic achievements are reflected in her continuous commitment to excellence in teaching and mentoring. She has significantly contributed to shaping the neurology curriculum at Stanford Medical School and has earned numerous awards, such as the A.B. Baker Teacher Recognition Award, further demonstrating her academic prowess and passion for education.

💼   Professional Experience 

Dr. Scheherazade Le currently serves as a Clinical Professor at the Department of Neurology at Stanford University, where she is responsible for teaching and supervising medical students, residents, and fellows in epilepsy, electroencephalography (EEG), and intraoperative neuromonitoring (IONM). Her professional trajectory includes various roles at Stanford University, ranging from Clinical Assistant Professor to Clinical Associate Professor. Throughout her tenure, she has led educational initiatives and clinical training for Stanford’s Neurology residency and fellowship programs. Dr. Le has been instrumental in course development for the Neuroscience Block (SOM223A), a second-year medical school course that she co-directs. She is also an invited lecturer for the Stanford Physician Assistant Program and actively participates in the Epilepsy Monitoring Unit. Dr. Le’s clinical work involves treating patients with epilepsy, neurophysiological conditions, and neurological disorders, while her academic efforts focus on curriculum development and innovative teaching methodologies.

🏅  Awards and Recognition 

Dr. Scheherazade Le has been recognized with numerous prestigious awards throughout her career. She was nominated for the American Academy of Neurology (AAN) Neuroscience Course Director Excellence Award in 2025 and received the A.B. Baker Teacher Recognition Award in 2024. Her commitment to educational excellence is further demonstrated by her receipt of the Stanford School of Medicine’s highest-rated course award for the Neuroscience Block (SOM223), which she has received multiple times, including in 2023 and 2024. Dr. Le’s work in neurology education also garnered her the Henry J. Kaiser Family Foundation Teaching Award Nominee for her contributions to medical education from 2022 to 2023. Other accolades include the Stanford Department of Neurology Lysia S. Forno Teaching Award and the Stanford Neurology Clerkship Medical Student Teaching Award. These honors reflect her dedication to advancing both the academic and clinical training of the next generation of neurologists.

🌍 Research Skill On Neuroscience

Dr. Scheherazade Le’s research interests lie at the intersection of clinical neurophysiology, epilepsy, and neuroimaging. She is particularly focused on advancing understanding and treatment methodologies for epilepsy and neurologic diseases through the use of electroencephalography (EEG) and intraoperative neuro-monitoring (IONM). Dr. Le’s research has contributed to the growing body of knowledge regarding brain-responsive neurostimulation in epilepsy patients with tuberous sclerosis complex. Additionally, she has been involved in studies concerning autoimmune encephalitis, psychogenic non-epileptic seizures, and the neurophysiology of abnormal movements. Her ability to bridge clinical practice with scientific investigation allows her to translate complex research findings into effective clinical treatments. Dr. Le is a key collaborator in multi-disciplinary research projects and has presented her work at regional neurophysiology and neuroimmunology conferences. Her ongoing research aims to improve diagnostic approaches and develop innovative therapies for neurological disorders, impacting both clinical practice and patient care.

 📖 Publication Top Notes

  • Cognitive and behavioral effects of perampanel 4 mg daily dose
    Authors: Meador, K.J., Seliger, J., Le, S., Loring, D.W., Gerard, E.
    Journal: Epilepsy and Behavior
    Year: 2025
    Volume: 164
  • Response to “Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration”
    Authors: Folmsbee, S.S., Gombar, S., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 126
  • Amnesia, Superior Altitudinal Anopia, and Reversed Clock Phenomenon due to Bilateral Posterior Cerebral Artery Infarcts
    Authors: Jindal, J.A., Le, S.T., Lansberg, M.G.
    Journal: Stroke
    Year: 2024
    Volume: 55(6)
  • Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study
    Authors: Sai Folmsbee, S., Hui, G., Yuan, Y., Han, M., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 124
  • Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures
    Authors: Rafferty, T., Koeppen-Babcock, A., Muppidi, S., Li, Y., Le, S.
    Journal: Epilepsy and Behavior
    Year: 2024
    Volume: 154
  • Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: A multi-centre cohort study
    Authors: Youngerman, B.E., Banu, M.A., Khan, F., D’Haese, P.-F., Wu, C.
    Journal: Journal of Neurology, Neurosurgery and Psychiatry
    Year: 2023
    Volume: 94(11)
  • Sharps Injuries Related to Subdermal Needles in the Orbicularis Oris During Intraoperative Neurophysiologic Monitoring
    Authors: Joshi, A., Aissa, Y., Le, S., Lee, L., Lopez, J.R.
    Journal: Journal of Clinical Neurophysiology
    Year: 2022
    Volume: 39(7)
  • A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes
    Authors: Werbaneth, K., Mausolf, M., Seliger, J., Le, S.
    Journal: Epileptic Disorders
    Year: 2022
    Volume: 24(5)
  • Direct brainstem somatosensory evoked potentials for cavernous malformations
    Authors: Le, S., Nguyen, V., Lee, L., Steinberg, G., López, J.
    Journal: Journal of Neurosurgery
    Year: 2022
    Volume: 137(1)
  • Hybrid Fluoroscopic and Neurophysiological Targeting of Responsive Neurostimulation of the Rolandic Cortex
    Authors: Parker, J.J., Jamiolkowski, R.M., Grant, G.A., Le, S., Halpern, C.H.
    Journal: Operative Neurosurgery
    Year: 2021
    Volume: 21(3)